VEON (VEON) Stock Price & Analysis

VEON (VEON) fell 1.87% to USD 51.01 as of July 25, 2026 at 04:29 UTC, according to Nexqual real-time market data.

VEON last closed at USD 51.98; the session ranged USD 51–52.59 on volume of 74,151 shares. Market capitalization is $3.53B, with a 52-week range of USD 42.6–64 (NMS). Source: Nexqual, July 25, 2026 at 04:29 UTC.

Key Statistics (as of July 25, 2026 at 04:29 UTC)

PriceUSD 51.01
Change▼ 1.87% (down)
Previous CloseUSD 51.98
OpenUSD 51.87
Day RangeUSD 51 – 52.59
52-Week RangeUSD 42.6 – 64
Volume74,151 shares
Market Cap$3.53B
ExchangeNMS

Technical Analysis (VEON)

Nexqual's technical model rates VEON "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:29 UTC.

Overall SignalSELL
RSI (14)43.95 (neutral)
vs SMA50Below (USD 52.97)
MACD-0.1 (negative)

Analyst Ratings (VEON)

Wall Street analysts rate VEON "None" based on 7 analysts, with a mean price target of USD 82.87 (range USD 70–100), per Nexqual as of July 25, 2026 at 04:29 UTC.

Consensus RatingNone
Analyst Count7
Mean TargetUSD 82.87
High TargetUSD 100
Low TargetUSD 70
Buy / Hold / Sell5 / 0 / 0

Earnings (VEON)

Next Earnings Date2026-07-31
EPS EstimateUSD 1.59
Revenue Estimate$1.23B

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 1.39 vs est 1.3 ▲ beat
2025-12-31USD -0.41 vs est 1.87 ▼ miss
2025-09-30USD -0.47 vs est 1.38 ▼ miss
2025-06-30USD 2.14 vs est 0.95 ▲ beat

Source: Nexqual, July 25, 2026 at 04:29 UTC.

Financials & Fundamentals (VEON)

Total Revenue$4.57B
Revenue Growth (YoY)+17.10%
Gross Margin+88.02%
Operating Margin+25.64%
Profit Margin+11.63%
ROE+36.67%
Debt / Equity291.09
Current Ratio0.86
Total Cash$2.18B
Total Debt$5.42B
Free Cash Flow$315.12M

Source: Nexqual, July 25, 2026 at 04:29 UTC.

Financial Health Score (VEON)

Nexqual rates VEON's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 04:29 UTC.

GrowthSolid — Revenue +10% YoY (annual)
ProfitabilityStrong — Gross margin 88%, operating 26%
Balance SheetCritical — $2.18B cash vs $5.42B debt
Cash FlowSolid — FCF $315M, 7% margin
EfficiencyStrong — ROE 37%, ROA 8.9%

Ownership (VEON)

Insider Ownership+0.06%
Institutional Ownership+25.55%
Shares Outstanding69.24M
Float62.66M
Short % of Float+0.60%

Source: Nexqual, July 25, 2026 at 04:29 UTC.

Leadership (VEON)

VEON is led by Muhterem Kaan Terzioglu (age 57), Group CEO & Director, per Nexqual as of July 25, 2026 at 04:29 UTC.

Group CEO & DirectorMuhterem Kaan Terzioglu (age 57)
Group Chief Financial OfficerBurak Ozer (age 53)

Major Backers & Investors (VEON)

Notable institutional backers of VEON include Lingotto Investment Management LLP, Shah Capital Management, Wellington Management, according to Nexqual as of July 25, 2026 at 04:29 UTC.

Active Investors

InvestorStake
Lingotto Investment Management LLP8.17%
Shah Capital Management6.61%
Wellington Management1.29%
Solus Alternative Asset Management LP1.2%
Morgan Stanley1.04%
Panview Capital Ltd0.75%
BNP Paribas Asset Management Holding S.A.0.68%
Global Macro Capital Opportunities Portfolio0.64%

Source: Nexqual, July 25, 2026 at 04:29 UTC.

Peers & Related Stocks

SymbolNamePriceChange
SONMDNA X, Inc.USD 3.15▲ 0.35%
IMPPImperial Petroleum Inc.USD 4.76▼ 1.04%
FAMIFarmmi, Inc. Ordinary SharesUSD 0.19▼ 3.6%
TONXTON Strategy CompanyUSD 3.24▼ 4.99%
SPCBSuperCom, Ltd.USD 10.71▼ 2.1%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:29 UTC. This page is informational and not investment advice.